Varex Imaging Corp
NASDAQ:VREX
Varex Imaging Corp
Cost of Revenue
Varex Imaging Corp
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
Varex Imaging Corp
NASDAQ:VREX
|
Cost of Revenue
-$578.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Varex Imaging Corp's Cost of Revenue?
Cost of Revenue
-578.6m
USD
Based on the financial report for Mar 29, 2024, Varex Imaging Corp's Cost of Revenue amounts to -578.6m USD.
What is Varex Imaging Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-2%
Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for Varex Imaging Corp have been -3% over the past three years , -2% over the past five years .